A multi-biomarker disease activity score was used in another recent study to evaluate its ability to predict sustained remission in RA, showing that its biomarkers IL-6, serum amyloid A (SAA), CRP, as well as leptin can differentiate between small differences in disease activity and are also predictors of one-year remission [68]. Here, IL6 is linked to rheumatoid arthritis.